Clinical Trial Update: The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study of daratumumab for patients with refractory aplastic anemia, focusing on safety and efficacy, with the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Daratumumab (daratumumab)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Aplastic Anemia, Refractory | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING